Campbell Michael Gerard 4

4 · Comera Life Sciences Holdings, Inc. · Filed Feb 16, 2023

Insider Transaction Report

Form 4
Period: 2023-02-14
Campbell Michael Gerard
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Purchase)

    2023-02-14+25,00025,000 total
    Exercise: $1.30Exp: 2033-02-14Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the stock option vest on February 14, 2024, with the remaining shares vesting on a monthly basis on the 14th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on February 14, 2027.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES